Difference between revisions of "Team:Bielefeld-CeBiTec/Results/HeavyMetals"

Line 227: Line 227:
 
     <p>Compared to the <i>in vivo</i> results, the response to arsenic was relatively small and we measured a high background signal. We assume that this is due to the different construct we used <i>in vitro</i>. This construct had been optimized for our CFPS by exchanging the natural promoter for the T7 promoter and exchanging mRFP1 for our optimized sfGFP. However, we assume that the repression in the presence of ArsR was not effective enough to observe a clear induction. The reason is most likely that the distance between the T7 promoter and the arsenic operator was too large. The distance was a result of our cloning strategy and would likely be suitable for <i>E. coli</i> promoters. However, the T7 promoter requires the operator to be very close for an efficient repression (<a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/HeavyMetals#Karig2012">Karig et al. 2012</a>). </p>
 
     <p>Compared to the <i>in vivo</i> results, the response to arsenic was relatively small and we measured a high background signal. We assume that this is due to the different construct we used <i>in vitro</i>. This construct had been optimized for our CFPS by exchanging the natural promoter for the T7 promoter and exchanging mRFP1 for our optimized sfGFP. However, we assume that the repression in the presence of ArsR was not effective enough to observe a clear induction. The reason is most likely that the distance between the T7 promoter and the arsenic operator was too large. The distance was a result of our cloning strategy and would likely be suitable for <i>E. coli</i> promoters. However, the T7 promoter requires the operator to be very close for an efficient repression (<a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/HeavyMetals#Karig2012">Karig et al. 2012</a>). </p>
 
     <p>In addition, we performed an experiment in which the arsenic repressor was not present in the reaction from the beginning, but was encoded on a second plasmid. The plasmid concentrations we used had been predicted by our model. In accordance with the aforementioned results, we observed no clear repression and addition of arsenic showed no effect. This experiment is discussed on the <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling/Application">Modeling pages</a>.</p>
 
     <p>In addition, we performed an experiment in which the arsenic repressor was not present in the reaction from the beginning, but was encoded on a second plasmid. The plasmid concentrations we used had been predicted by our model. In accordance with the aforementioned results, we observed no clear repression and addition of arsenic showed no effect. This experiment is discussed on the <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling/Application">Modeling pages</a>.</p>
 +
    <h2>To summarize</h2>
 +
<p>The arsenic sensor is the most prominent example of heavy metal biosensors. Our results confirm that it is possible to detect the safety limit of 10 µg/L arsenic with a cell-based arsenic senosor. The results of the tests in our CFPS indicate that this approach is suitable for the detection of arsenic as well. However, we believe that the genetic construct requires further optimization.</p>
 +
 +
<h3>References</h3>
 +
<p id="Chen2014">Chen, Jian; Rosen, Barry P. (2014): Biosensors for inorganic and organic arsenicals. In Biosensors 4 (4), pp. 494–512. DOI: 10.3390/bios4040494.</p>
 +
    <p id="Karig2012">Karig, David K.; Iyer, Sukanya; Simpson, Michael L.; Doktycz, Mitchel J. (2012): Expression optimization and synthetic gene networks in cell-free systems. In Nucleic acids research 40 (8), pp. 3763–3774. DOI: 10.1093/nar/gkr1191.</p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 276: Line 282:
  
  
</br><p>Our data lead to the conclusion that in a cell based system it is possible to detect chromium. In contrast to our expectations with higher chromium concentrations we got lower fluorescence levels. These observations needed further investigation. Additionally the bar chart showed that the chromium sensor needs a long time to get different fluorescence levels at different chromium concentrations in <i>in vivo </i> experiments. The bar chart showed significant differences between the chromium concentrations after 650 minutes. </p>
+
</br><p>Our data lead to the conclusion that in a cell-based system it is possible to detect chromium. In contrast to our expectations with higher chromium concentrations we got lower fluorescence levels. These observations needed further investigation. Additionally the bar chart showed that the chromium sensor needs a long time to get different fluorescence levels at different chromium concentrations in <i>in vivo </i> experiments. The bar chart showed significant differences between the chromium concentrations after 650 minutes. </p>
  
 
<h2><i>in vitro</i></h2>
 
<h2><i>in vitro</i></h2>
Line 285: Line 291:
 
<div class="row">
 
<div class="row">
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 1000px">
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 1000px">
   <a href="https://static.igem.org/mediawiki/2015/e/e4/Bielefeld-CeBiTec_in_vitro_ChrB-part.jpeg" data-lightbox="heavymetals" data-title="Figure 5: To produce the cell extract for <i>in vitro</i> characterization a construct (BBa_K1758310 ) with chromium repressor under the control of a constitutive promoter and strong RBS (BBa_K608002)  is needed. " https://static.igem.org/mediawiki/2015/e/e4/Bielefeld-CeBiTec_in_vitro_ChrB-part.jpeg" alt="repressor construct used for in vivo characterization."><img src=" https://static.igem.org/mediawiki/2015/e/e4/Bielefeld-CeBiTec_in_vitro_ChrB-part.jpeg" alt="repressor construct used for in vivo characterisation"></a> <figcaption> Figure 5: To produce the cell extract for <i>in vitro</i> characterization a construct (<a href="http://parts.igem.org/Part:BBa_K1758310" target="_blank">BBa_K1758310</a> ) with chromium repressor under the control of a constitutive promoter and strong RBS (BBa_K608002)  is needed.</figcaption>
+
   <a href="https://static.igem.org/mediawiki/2015/e/e4/Bielefeld-CeBiTec_in_vitro_ChrB-part.jpeg" data-lightbox="heavymetals" data-title="Figure 5: To produce the cell extract for <i>in vitro</i> characterization a construct (BBa_K1758310 ) with chromium repressor under the control of a constitutive promoter and strong RBS (BBa_K608002)  is needed. "><img src=" https://static.igem.org/mediawiki/2015/e/e4/Bielefeld-CeBiTec_in_vitro_ChrB-part.jpeg" alt="repressor construct used for in vivo characterisation"></a> <figcaption> Figure 5: To produce the cell extract for <i>in vitro</i> characterization a construct (<a href="http://parts.igem.org/Part:BBa_K1758310" target="_blank">BBa_K1758310</a> ) with chromium repressor under the control of a constitutive promoter and strong RBS (BBa_K608002)  is needed.</figcaption>
 
</figure>
 
</figure>
 
     </div>
 
     </div>
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 600px">
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 600px">
   <a href="https://static.igem.org/mediawiki/2015/1/1f/Bielefeld-CebiTec_in_vitro_T7-chrP-UTR-sfGFP.jpeg" data-lightbox="heavymetals" data-title="T7-chrP-UTR-sfGFP construct used for<i>in vitro</i> characterization." https://static.igem.org/mediawiki/2015/1/1f/Bielefeld-CebiTec_in_vitro_T7-chrP-UTR-sfGFP.jpeg" alt="promoter construct used for in vivo characterization."><img src=" https://static.igem.org/mediawiki/2015/1/1f/Bielefeld-CebiTec_in_vitro_T7-chrP-UTR-sfGFP.jpeg" alt="promoter construct used for in vivo characterisation "></a> <figcaption> T7-chrP-UTR-sfGFP <a href="http://parts.igem.org/Part:BBa_K1758314" target="_blank">BBa_K1758314</a> used for<i>in vitro</i> characterization.</figcaption>
+
   <a href="https://static.igem.org/mediawiki/2015/1/1f/Bielefeld-CebiTec_in_vitro_T7-chrP-UTR-sfGFP.jpeg" data-lightbox="heavymetals" data-title="T7-chrP-UTR-sfGFP construct used for<i>in vitro</i> characterization."><img src=" https://static.igem.org/mediawiki/2015/1/1f/Bielefeld-CebiTec_in_vitro_T7-chrP-UTR-sfGFP.jpeg" alt="promoter construct used for in vivo characterisation "></a> <figcaption> T7-chrP-UTR-sfGFP <a href="http://parts.igem.org/Part:BBa_K1758314" target="_blank">BBa_K1758314</a> used for<i>in vitro</i> characterization.</figcaption>
 
</figure>   
 
</figure>   
 
         </div>
 
         </div>
Line 347: Line 353:
 
<p>In addition to the measurements of our chromium sensor in CFPS we measured our chromium inducible promoter with the repressor of team Dundee (figure 10, 11), which works similar to ours. In contrast to our repressor only first 15 codons of their repressor are codon-optimized. Measurements with their repressor showed tendencies similar to our measured repressor. After normalization induction with higher chromium concentrations showed a detectable fluorescence response for both measured datasets. </p>
 
<p>In addition to the measurements of our chromium sensor in CFPS we measured our chromium inducible promoter with the repressor of team Dundee (figure 10, 11), which works similar to ours. In contrast to our repressor only first 15 codons of their repressor are codon-optimized. Measurements with their repressor showed tendencies similar to our measured repressor. After normalization induction with higher chromium concentrations showed a detectable fluorescence response for both measured datasets. </p>
  
<h3>References</h3>
+
 
 +
<h2>To summarize<h2>
 +
<p>Our chromium sensor detects the presence of chromium <i>in vivo</i>, but the outcome differed from our expectations. We would have expected an increase in fluorescence by increasing chromium concentrations. Our <i>in vitro</i> data suggest that these decrease in fluorescence could be explained by chromium’s influence on <i>E. coli</i> which is not reflected in growth but shown by chromium´s influence on the cell extract. Before normalizing the <i>in vitro</i> data the same pattern as <i>in vivo</i> could be observed. After normalization an increase in signal is noticeable. Therefore with optimization our chromium sensor would be compatible to our cell free sensor system.</p>
 +
   
 +
    <h3>References</h3>
 
<div class="references">
 
<div class="references">
 
<p> Guidelines for drinking-water quality (2011). 4th ed. Geneva: World Health Organization, zuletzt geprüft am 20.08.2015.</p>
 
<p> Guidelines for drinking-water quality (2011). 4th ed. Geneva: World Health Organization, zuletzt geprüft am 20.08.2015.</p>
Line 355: Line 365:
 
</p>
 
</p>
 
</div>
 
</div>
 
<h2>summarize<h2>
 
<p>Our chromium sensor detects the presence of chromium <i>in vivo</i>, but the outcome differed from our expectations. We would have expected an increase in fluorescence by increasing chromium concentrations. Our <i>in vitro</i> data suggest that these decrease in fluorescence could be explained by chromium’s influence on <i>E. coli</i> which is not reflected in growth but shown by chromium´s influence on the cell extract. Before normalizing the <i>in vitro</i> data the same pattern as <i>in vivo</i> could be observed. After normalization an increase in signal is noticeable. Therefore with optimization our chromium sensor would be compatible to our cell free sensor system.</p>
 
 
</div>
 
</div>
  
Line 419: Line 426:
 
     </div>
 
     </div>
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 400px">
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 400px">
   <a href=" https://static.igem.org/mediawiki/2015/1/15/Bielefeld-CebiTec_in_vitro_T7-copAP-UTR-sfGFP.jpeg " data-lightbox="heavymetals" data-title="Figure 6:T7-copAP-UTR-sfGFP construct used for <i>in vitro</i> characterization." https://static.igem.org/mediawiki/2015/1/15/Bielefeld-CebiTec_in_vitro_T7-copAP-UTR-sfGFP.jpeg " alt="promoter construct used for in vivo characterization."><img src=" https://static.igem.org/mediawiki/2015/1/15/Bielefeld-CebiTec_in_vitro_T7-copAP-UTR-sfGFP.jpeg " alt="promoter construct used for in vivo characterisation "></a> <figcaption>Figure 6: T7-copAP-UTR-sfGFP <a href="http://parts.igem.org/Part:BBa_K1758325" target="_blank">BBa_K1758325</a> used for <i>in vitro</i> characterization. </figcaption>
+
   <a href=" https://static.igem.org/mediawiki/2015/1/15/Bielefeld-CebiTec_in_vitro_T7-copAP-UTR-sfGFP.jpeg " data-lightbox="heavymetals" data-title="Figure 6:T7-copAP-UTR-sfGFP construct used for <i>in vitro</i> characterization."><img src=" https://static.igem.org/mediawiki/2015/1/15/Bielefeld-CebiTec_in_vitro_T7-copAP-UTR-sfGFP.jpeg " alt="promoter construct used for in vivo characterisation "></a> <figcaption>Figure 6: T7-copAP-UTR-sfGFP <a href="http://parts.igem.org/Part:BBa_K1758325" target="_blank">BBa_K1758325</a> used for <i>in vitro</i> characterization. </figcaption>
 
</figure>   
 
</figure>   
 
         </div>
 
         </div>
Line 482: Line 489:
  
 
<p>After normalizing on coppers influence to the cell extract these differences were even more obvious.</p>
 
<p>After normalizing on coppers influence to the cell extract these differences were even more obvious.</p>
 
 
<h3>References</h3>
 
<div class="references"><p id="Guidelines for Drinking-water Quality, Fourth Edition "> Background document for development of WHO Guidelines for Drinking-water Quality, checked on 9/9/2015. Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease - Brewer - 2012 - BioFactors - Wiley Online Library. Available online at http://onlinelibrary.wiley.com/doi/10.1002/biof.1005/abstract, checked on 8/28/2015. </p><p id=" US EPA ORD NCEA Integrated Risk Information System (IRIS) 2014"> US EPA ORD NCEA Integrated Risk Information System (IRIS) (2014): Copper (CASRN 7440-50-8) | IRIS | US EPA. Available online at http://www.epa.gov/iris/subst/0368.htm, updated on 10/31/2014, checked on 9/2/2015.</p></div>
 
  
  
Line 491: Line 494:
 
<h2>To summarize</h2>
 
<h2>To summarize</h2>
 
<p>Our copper sensors <i>in vivo</i> data show that detection of different copper concentrations is possible. The fluorescence levels differ clearly between different induction concentrations. As shown above higher copper concentration, higher the fluorescence signal. Therefore the concept of our sensor is functional even if the concentration needed for induction are to high to reach sensitively concerning the WHO guidelines for copper. Our sensor has been tested <i>in vitro</i> as well. For copper we tested our original CopAP construct without a T7 promoter in front of the inducible at first.  After realizing that the sensor shows the right tendencies but the general fluorescence is quite low we created an inducible promoter under the control of a T7 promoter to use in CFPS. Fluorescence levels of this device showed the same tendencies as the one without but were higher fluorescence’s, which helps detecting it.</p>
 
<p>Our copper sensors <i>in vivo</i> data show that detection of different copper concentrations is possible. The fluorescence levels differ clearly between different induction concentrations. As shown above higher copper concentration, higher the fluorescence signal. Therefore the concept of our sensor is functional even if the concentration needed for induction are to high to reach sensitively concerning the WHO guidelines for copper. Our sensor has been tested <i>in vitro</i> as well. For copper we tested our original CopAP construct without a T7 promoter in front of the inducible at first.  After realizing that the sensor shows the right tendencies but the general fluorescence is quite low we created an inducible promoter under the control of a T7 promoter to use in CFPS. Fluorescence levels of this device showed the same tendencies as the one without but were higher fluorescence’s, which helps detecting it.</p>
 +
   
 +
    <h3>References</h3>
 +
<div class="references"><p id="Guidelines for Drinking-water Quality, Fourth Edition "> Background document for development of WHO Guidelines for Drinking-water Quality, checked on 9/9/2015. Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease - Brewer - 2012 - BioFactors - Wiley Online Library. Available online at http://onlinelibrary.wiley.com/doi/10.1002/biof.1005/abstract, checked on 8/28/2015. </p><p id=" US EPA ORD NCEA Integrated Risk Information System (IRIS) 2014"> US EPA ORD NCEA Integrated Risk Information System (IRIS) (2014): Copper (CASRN 7440-50-8) | IRIS | US EPA. Available online at http://www.epa.gov/iris/subst/0368.htm, updated on 10/31/2014, checked on 9/2/2015.</p></div>
 
</div>
 
</div>
  
Line 508: Line 514:
  
 
  <figure style="width: 600px">
 
  <figure style="width: 600px">
<a href="https://static.igem.org/mediawiki/2015/a/a3/Bielefeld-CebiTec_in_vivo_Lead.jpeg" data-lightbox="heavymetals" data-title="The concept of our <i>in vivo</i> lead sensor (<a href="http://parts.igem.org/Part:BBa_K1758332" target="_blank"> BBa_K1758332</a>), which consists of the repressor under the control of a constitutive promoter (<a href="http://parts.igem.org/Part:BBa_K1758330" target="_blank"> BBa_K17583230</a>) and the operator and promoter sequence of the lead inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression  (<a href="http://parts.igem.org/Part:BBa_K1758332" target="_blank"> BBa_K1758332</a>)."><img src="https://static.igem.org/mediawiki/2015/a/a3/Bielefeld-CebiTec_in_vivo_Lead.jpeg" alt="genetical approach"></a>
+
<a href="https://static.igem.org/mediawiki/2015/a/a3/Bielefeld-CebiTec_in_vivo_Lead.jpeg" data-lightbox="heavymetals" data-title="The concept of our <i>in vivo</i> lead sensor (BBa_K1758332), which consists of the repressor under the control of a constitutive promoter (BBa_K17583230) and the operator and promoter sequence of the lead inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression  (BBa_K1758332)."><img src="https://static.igem.org/mediawiki/2015/a/a3/Bielefeld-CebiTec_in_vivo_Lead.jpeg" alt="genetical approach"></a>
<figcaption>Figure 2: Figure 2: The concept of our in vivo lead sensor  (<a href="http://parts.igem.org/Part:BBa_K1758332" target="_blank"> BBa_K1758332</a>)which consists of the repressor under the control of a constitutive promoter  (<a href="http://parts.igem.org/Part:BBa_K1758330" target="_blank"> BBa_K17583230</a>) and the operator and promoter sequence of the lead inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression  (<a href="http://parts.igem.org/Part:BBa_K1758332" target="_blank"> BBa_K1758332</a>).</figcaption>
+
<figcaption>Figure 2: The concept of our in vivo lead sensor  (<a href="http://parts.igem.org/Part:BBa_K1758332" target="_blank"> BBa_K1758332</a>)which consists of the repressor under the control of a constitutive promoter  (<a href="http://parts.igem.org/Part:BBa_K1758330" target="_blank"> BBa_K17583230</a>) and the operator and promoter sequence of the lead inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression  (<a href="http://parts.igem.org/Part:BBa_K1758332" target="_blank"> BBa_K1758332</a>).</figcaption>
 
</figure>
 
</figure>
  
Line 530: Line 536:
 
<p> The results of the lead sensor show no significant differences between the different concentrations (figure 3). This might be due to the <i>pbrAP’s</i> weak promoter strength in <i>E. coli.</i> Further reasons are most likely in the weak repressor binding to its operator.  So, we suggest for the usage of this sensor, it has to be optimized. Moreover we were lacking time for further in vivo characterizations and different experimental setups. Hence, we did not use this sensor in further experiments regarding Cell-free-Protein-synthesis (CFPS). . In the future a characterization in the CFPS systems would be desirable.  </p>
 
<p> The results of the lead sensor show no significant differences between the different concentrations (figure 3). This might be due to the <i>pbrAP’s</i> weak promoter strength in <i>E. coli.</i> Further reasons are most likely in the weak repressor binding to its operator.  So, we suggest for the usage of this sensor, it has to be optimized. Moreover we were lacking time for further in vivo characterizations and different experimental setups. Hence, we did not use this sensor in further experiments regarding Cell-free-Protein-synthesis (CFPS). . In the future a characterization in the CFPS systems would be desirable.  </p>
  
<h3>References</h3>
+
 
 +
<h2>To summarize</h2>
 +
<p>Our lead sensor was characterized <i>in vivo</i> only. The differences between inductions with various lead concentrations are really slight therefore this sensor needs further optimization which was not possible in this limited time. But as there is a fluorescence response to lead this sensor has the potential work as expected. In the future a characterization in CFPS systems would be interesting.</p>
 +
   
 +
    <h3>References</h3>
 
<div class="references">
 
<div class="references">
 
<p id="EPA"> EPA Health Effects: How Lead Affects the body, checked on 2015-09-17. </p>
 
<p id="EPA"> EPA Health Effects: How Lead Affects the body, checked on 2015-09-17. </p>
Line 537: Line 547:
 
  </p>
 
  </p>
 
</div>
 
</div>
 
 
<h2>To summarize</h2>
 
<p>Our lead sensor was characterized <i>in vivo</i> only. The differences between inductions with various lead concentrations are really slight therefore this sensor needs further optimization which was not possible in this limited time. But as there is a fluorescence response to lead this sensor has the potential work as expected. In the future a characterization in CFPS systems would be interesting.</p>
 
 
</div>
 
</div>
  
Line 560: Line 566:
  
 
<figure style="width: 600px">
 
<figure style="width: 600px">
<a href="https://static.igem.org/mediawiki/2015/0/0d/Bielefeld-CebiTec_in_vivo_Mercury.jpeg" data-lightbox="heavymetals" data-title=" Figure 2:  The concept of our <i>in vivo</i> mercury sensor (<a href="http://parts.igem.org/Part:BBa_K1758343" target="_blank"> BBa_K1758343</a>), which consists of the activator under the control of a constitutive promoter  <a href="http://parts.igem.org/Part:BBa_K1758340" target="_blank"> BBa_K1758340</a>)and the operator and promoter sequence of the mercury inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (<a href="http://parts.igem.org/Part:BBa_K1758342" target="_blank"> BBa_K1758342</a>)."><img src="https://static.igem.org/mediawiki/2015/0/0d/Bielefeld-CebiTec_in_vivo_Mercury.jpeg"></a>
+
<a href="https://static.igem.org/mediawiki/2015/0/0d/Bielefeld-CebiTec_in_vivo_Mercury.jpeg" data-lightbox="heavymetals" data-title=" Figure 2:  The concept of our <i>in vivo</i> mercury sensor (BBa_K1758343), which consists of the activator under the control of a constitutive promoter  (BBa_K1758340)and the operator and promoter sequence of the mercury inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (BBa_K1758342)."><img src="https://static.igem.org/mediawiki/2015/0/0d/Bielefeld-CebiTec_in_vivo_Mercury.jpeg"></a>
 
<figcaption>Figure 2:  The concept of our <i>in vivo</i> mercury sensor (<a href="http://parts.igem.org/Part:BBa_K1758343" target="_blank"> BBa_K1758343</a>), which consists of the activator under the control of a constitutive promoter  <a href="http://parts.igem.org/Part:BBa_K1758340" target="_blank"> BBa_K1758340</a>)and the operator and promoter sequence of the mercury inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (<a href="http://parts.igem.org/Part:BBa_K1758342" target="_blank"> BBa_K1758342</a>).</figcaption>
 
<figcaption>Figure 2:  The concept of our <i>in vivo</i> mercury sensor (<a href="http://parts.igem.org/Part:BBa_K1758343" target="_blank"> BBa_K1758343</a>), which consists of the activator under the control of a constitutive promoter  <a href="http://parts.igem.org/Part:BBa_K1758340" target="_blank"> BBa_K1758340</a>)and the operator and promoter sequence of the mercury inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (<a href="http://parts.igem.org/Part:BBa_K1758342" target="_blank"> BBa_K1758342</a>).</figcaption>
 
</figure>
 
</figure>
Line 603: Line 609:
 
     </div>
 
     </div>
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 400px">
 
     <div class="col-md-6 text-center" style="margin-bottom: 50px"> <figure style="width: 400px">
   <a href=" https://static.igem.org/mediawiki/2015/e/e2/Bielefeld-CebiTec_in_vitro_T7-merT-UTR-sfGFP.jpeg " data-lightbox="heavymetals" data-title="T7-PmerT-UTR-sfGFP used for<i>in vitro</i> characterization." https://static.igem.org/mediawiki/2015/e/e2/Bielefeld-CebiTec_in_vitro_T7-merT-UTR-sfGFP.jpeg " alt="promoter construct used for in vivo characterization."><img src=" https://static.igem.org/mediawiki/2015/e/e2/Bielefeld-CebiTec_in_vitro_T7-merT-UTR-sfGFP.jpeg" alt="promoter construct used for in vivo characterisation "></a> <figcaption>T7-<i>PmerT</i>-UTR-sfGFP <a href="http://parts.igem.org/Part:BBa_K1758344" target="_blank"> BBa_K175844</a> used for<i>in vitro</i> characterization.</figcaption>
+
   <a href=" https://static.igem.org/mediawiki/2015/e/e2/Bielefeld-CebiTec_in_vitro_T7-merT-UTR-sfGFP.jpeg " data-lightbox="heavymetals" data-title="T7-PmerT-UTR-sfGFP used for<i>in vitro</i> characterization."><img src=" https://static.igem.org/mediawiki/2015/e/e2/Bielefeld-CebiTec_in_vitro_T7-merT-UTR-sfGFP.jpeg" alt="promoter construct used for in vivo characterisation "></a> <figcaption>T7-<i>PmerT</i>-UTR-sfGFP <a href="http://parts.igem.org/Part:BBa_K1758344" target="_blank"> BBa_K175844</a> used for<i>in vitro</i> characterization.</figcaption>
 
</figure>   
 
</figure>   
 
         </div>
 
         </div>
Line 664: Line 670:
 
   
 
   
 
  <figure style="width: 600px">
 
  <figure style="width: 600px">
<a href="https://static.igem.org/mediawiki/2015/8/8e/Bielefeld-CebiTec_in_vivo_Nickel.jpeg" data-lightbox="heavymetals" data-title=" Figure 2: The concept of our <i>in vivo</i> nickel sensor (<a href="http://parts.igem.org/Part:BBa_K1758354" target="_blank"> BBa_K1758354</a>), which consists of the activator under the control of a constitutive promoter (<a href="http://parts.igem.org/Part:BBa_K1758350" target="_blank"> BBa_K1758350</a>)and the operator and promoter sequence of the nickel inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (<a href="http://parts.igem.org/Part:BBa_K1758352" target="_blank"> BBa_K1758352</a>) "><img src="https://static.igem.org/mediawiki/2015/8/8e/Bielefeld-CebiTec_in_vivo_Nickel.jpeg"></a>
+
<a href="https://static.igem.org/mediawiki/2015/8/8e/Bielefeld-CebiTec_in_vivo_Nickel.jpeg" data-lightbox="heavymetals" data-title=" Figure 2: The concept of our <i>in vivo</i> nickel sensor (BBa_K1758354), which consists of the activator under the control of a constitutive promoter (BBa_K1758350)and the operator and promoter sequence of the nickel inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (BBa_K1758352) "><img src="https://static.igem.org/mediawiki/2015/8/8e/Bielefeld-CebiTec_in_vivo_Nickel.jpeg"></a>
 
<figcaption>Figure 2: The concept of our <i>in vivo</i> nickel sensor (<a href="http://parts.igem.org/Part:BBa_K1758354" target="_blank"> BBa_K1758354</a>), which consists of the activator under the control of a constitutive promoter (<a href="http://parts.igem.org/Part:BBa_K1758350" target="_blank"> BBa_K1758350</a>)and the operator and promoter sequence of the nickel inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (<a href="http://parts.igem.org/Part:BBa_K1758352" target="_blank"> BBa_K1758352</a>) </figcaption> </figure>
 
<figcaption>Figure 2: The concept of our <i>in vivo</i> nickel sensor (<a href="http://parts.igem.org/Part:BBa_K1758354" target="_blank"> BBa_K1758354</a>), which consists of the activator under the control of a constitutive promoter (<a href="http://parts.igem.org/Part:BBa_K1758350" target="_blank"> BBa_K1758350</a>)and the operator and promoter sequence of the nickel inducible promoter. An untranslated region in front of the sfGFP, which is used for detection, enhances its expression (<a href="http://parts.igem.org/Part:BBa_K1758352" target="_blank"> BBa_K1758352</a>) </figcaption> </figure>
  
Line 696: Line 702:
 
</div>
 
</div>
  
</div>
 
  
</div>
 
 
    
 
    
 
<div class="row footer">
 
<div class="row footer">

Revision as of 15:27, 29 October 2015

iGEM Bielefeld 2015


Heavy Metals

Results

Adjusting the detection limit
Figure 1: Influence of heavy metals on the growth of E.coli KRX. The tested concentrations were 20 µg/L lead, 60 µg/L mercury, 60 µg/L chromium, 80 µg/L nickel, 40 mg/L copper, which represent ten times the WHO guideline. The influence of arsenic was not tested as E. coli is known to be resistant to arsenic.

We tested our heavy metal biosensors in Escherichia coli as well as in our cell-free protein synthesis.

Prior to the in vivo characterization, we tested whether the heavy metals have a negative effect on the growth of E. coli.

As can be seen from the figure, we observed no significant difference between the growth in the presence of heavy metals and the controls. This first experiment showed us that in vivo characterization of these sensors is possible. Most cultivations for in vivo characterization were performed in the BioLector. Due to the accuracy of this device, we could measure our samples in duplicates. Subsequently, all functional biosensors were tested in vitro.

Click on the test strip for the results of our biosensor tests in E. coli and in our CFPS:

teststrip

To summarize all

We have characterized heavy metal sensors for arsenic, chromium, copper, lead, mercury and nickel. The results for our nickel characterization indicated that the constructed nickel sensor is not suitable for our test strip. The sensors for lead and chromium showed great potential, as they showed responses to chromium or lead, but require further optimization. Copper, our new heavy metal sensor, worked as expected and was able to detect different copper concentrations. The already well-characterized sensors for arsenic and mercury were tested as well. While the arsenic sensor worked well in vivo, it requires some omptimization for the use in vitro. Mercury showed that a fully optimized sensor works very well in our in vitro system and has the potential to detect even lower concentrations than in vivo.